Moral Entrepreneurship: Integrating Equity within Antimicrobial Resistance Innovation
Ximena Benavides (Yale University), Moral Entrepreneurship: Integrating Equity within Antimicrobial Resistance Innovation (Mercatus Rsch. Paper forthcoming) (2022): The AMR public health threat and the surge of AMR entrepreneurship initiatives under the current biopharmaceutical innovation ecosystem offer policy and industry decision-makers... (Source: HealthLawProf Blog)
Source: HealthLawProf Blog - March 14, 2024 Category: Medical Law Authors: Katharine Van Tassel Source Type: blogs
Antimicrobial resistance in critically ill patients
(Source: Notes from Dr. RW)
Source: Notes from Dr. RW - February 2, 2023 Category: Internal Medicine Tags: critical care infectious disease Source Type: blogs
Antimicrobial resistance national action plan: call for evidence
Department of Health and Social Care - The government is developing the next five year national action plan on antimicrobial resistance (AMR). The plan will run from 2024 until 2029. The action plan will be part of a programme to tackle AMR and achieve the UK ’s vision for AMR to be contained and controlled by 2040. The closing date for comments is 20 January 2023.Consultation responseDepartment of Health and Social Care - consultations (Source: Health Management Specialist Library)
Source: Health Management Specialist Library - November 23, 2022 Category: UK Health Authors: The King ' s Fund Library Tags: Consultations Public health and health inequalities Source Type: blogs
Powering the UK ’s approach to AMR: the future of AMR policy
Reform -Antimicrobial resistance (AMR) is a major challenge to the UK ’s health security, and is responsible for a significant burden of death, disability and prolonged illness globally. A Reform report published in 2020 highlighted the threat of AMR and made a number of key proposals for reform. This briefing paper draws on a roundtable to assess progress made agai nst these proposals. It takes learnings from the Covid-19 pandemic to provide practical actions that Government could implement to drive change, with a particular focus on the role of rapid, accurate diagnostics in supporting surveillance and managing infecti...
Source: Health Management Specialist Library - November 17, 2022 Category: UK Health Authors: The King ' s Fund Library Tags: Public health and health inequalities Source Type: blogs
Are antibiotics too much of a good thing?
Since the development of antibiotics in the 1940s, patients presenting with an infection could be expected to respond quickly to a prescribed course of antibiotics by their physician. While the antibiotic prescription model has helped countless lives, this paradigm has degraded over time due to the emergence of antimicrobial resistance (AMR). The net impact is
Read more…
Are antibiotics too much of a good thing? originally appeared in KevinMD.com. (Source: Kevin, M.D. - Medical Weblog)
Source: Kevin, M.D. - Medical Weblog - October 3, 2022 Category: General Medicine Authors: Anthony J. Senagore, MD, MBA Tags: Meds Infectious Disease Source Type: blogs
Combating antimicrobial resistance during COVID [PODCAST]
Subscribe to The Podcast by KevinMD. Catch up on old episodes! “While the world has spent the last two years laser-focused on the COVID pandemic, another public health threat is still lurking in the shadows: the rise of antibiotic-resistant bacteria. Antimicrobial resistance (AMR) has been recognized since the early 1900s, yet rigorous research over the
Read more…
Combating antimicrobial resistance during COVID [PODCAST] originally appeared in KevinMD.com. (Source: Kevin, M.D. - Medical Weblog)
Source: Kevin, M.D. - Medical Weblog - August 30, 2022 Category: General Medicine Authors: The Podcast by KevinMD Tags: Podcast COVID Source Type: blogs
Combatting antimicrobial resistance during COVID: What clinicians need to know
While the world has spent the last two years laser-focused on the COVID pandemic, another public health threat is still lurking in the shadows: the rise of antibiotic-resistant bacteria. Antimicrobial resistance (AMR) has been recognized since the early 1900s, yet rigorous research over the past decade has illuminated the magnitude of the threat and itsRead more …Combatting antimicrobial resistance during COVID: What clinicians need to know originally appeared inKevinMD.com. (Source: Kevin, M.D. - Medical Weblog)
Source: Kevin, M.D. - Medical Weblog - May 28, 2022 Category: General Medicine Authors: < span itemprop="author" > < a href="https://www.kevinmd.com/post-author/anne-meneghetti" rel="tag" data-wpel-link="internal" > Anne Meneghetti, MD < /a > < /span > Tags: Conditions COVID Infectious Disease Source Type: blogs
Tackling antimicrobial resistance 2019 to 2024: addendum to the UK's 5-year national action plan
Department of Health and Social Care - This policy paper sets out changes to the commitments inTackling antimicrobial resistance 2019 to 2024: the UK ’s five-year national action plan, in its third year of delivery. The changes reflect lessons learnt from the Covid-19 pandemic and progress that has already been made.Policy paperMore detail (Source: Health Management Specialist Library)
Source: Health Management Specialist Library - May 17, 2022 Category: UK Health Authors: The King ' s Fund Library Tags: Public health and health inequalities Source Type: blogs
TWiV 870: COVID-19 clinical update #103 with Dr. Daniel Griffin
In COVID-19 clinical update #103, Daniel Griffin covers immunocompromised people, hospitalization of children, vaccine usage update, Omicron and cross-reactive neutralizing antibodies, reinfection prevents disease in hamsters, repeated infections with endemic coronaviruses, global burden of antimicrobial resistance, ivermectin not protective in hamsters, and Omicron evades therapeutic monoclonals. Click arrow to playDownload TWiV 870 (52 MB .mp3, 43 […] (Source: virology blog)
Source: virology blog - February 26, 2022 Category: Virology Authors: Vincent Racaniello Tags: This Week in Virology antiviral coronavirus COVID-19 delta inflammation Long Covid monoclonal antibody Omicron pandemic SARS-CoV-2 vaccine vaccine booster variant of concern viruses Source Type: blogs
Fight Aging! Newsletter, December 27th 2021
We report that whereas microglia are characterized by marked gene-level alterations related to negative regulation of protein phosphorylation and phagocytic vesicles, astrocytes show activation of enzyme- or peptidase-inhibitor signaling after detectable changes in BBB permeability. We also identify several genes enriched in these pathways that are notably altered after BBB breakdown. Our data reveal that microglia and astrocytes play an active role in maintaining BBB stabilization and corralling infiltrating cells, and thus might potentially function in ameliorating the lesions and neurologic disabilities in CNS diseases....
Source: Fight Aging! - December 26, 2021 Category: Research Authors: Reason Tags: Newsletters Source Type: blogs
Delivering Catalase to Treat Sepsis
Sepsis is a state of runaway inflammation in response to infection, a condition that is more serious and more often fatal in older individuals. With age, the immune system becomes every more overactive and inflammatory, reacting to signals created by the damaged environment of the body. This background of chronic inflammation makes it ever less likely that any given incident of greatly raised inflammatory signaling will successfully resolve. Instead inflammation can rage to the point of causing serious harm and organ failure.
At present, treatments for sepsis are largely palliative, or focus on removing the infectio...
Source: Fight Aging! - December 21, 2021 Category: Research Authors: Reason Tags: Medicine, Biotech, Research Source Type: blogs
Chip Detects Antibiotics in Exhaled Breath
Researchers at the University of Freiburg in Germany have developed a chip that can measure antibiotic levels in breath, potentially paving the way for rapid point-of-care antibiotic testing. Attaining the correct levels of antibiotics in the body is crucial to effectively treating infections and avoiding drug side-effects or the development of antibiotic-resistant bacteria. The chip enables rapid and non-invasive antibiotic testing, potentially allowing for personalized drug therapy.
Antimicrobial resistance is a growing issue, and owes its proliferation to incorrect antibiotic usage. If administered at too low a dose,...
Source: Medgadget - September 29, 2021 Category: Medical Devices Authors: Conn Hastings Tags: Medicine Source Type: blogs
The fight to curb antimicrobial resistance: how are we doing?
(Source: Notes from Dr. RW)
Source: Notes from Dr. RW - August 11, 2021 Category: Internal Medicine Tags: hospital medicine infectious disease pharmacology quality and safety Source Type: blogs
Engineered Surfaces Reduce Bacterial Attachment and Growth
Researchers at Monash University in Australia have developed a technique to create 3D engineered surfaces that reduce bacterial growth. Their approach could lead to frequently touched surfaces in healthcare facilities that result in less bacterial transmission. This should lead to a reduction in the incidence of hospital acquired infections, such as urinary tract infections in patients with urinary catheters.
Approximately 20% of patients are fitted with a urinary catheter during hospitalization, meaning a huge number of people suffer urinary tract infections. Such infections can be difficult to treat, particularly if a...
Source: Medgadget - May 24, 2021 Category: Medical Devices Authors: Conn Hastings Tags: Materials Public Health Source Type: blogs
Pills and the planet: Environmentally-friendly steps for your medicine cabinet
Most people might not guess that pills (or creams, patches, and inhalers, for that matter) have a big impact on the environment — but they do.
Climate change is leading to noticeable effects on the environment, as well as to consequences for our health, such as rising rates of asthma and new patterns of infectious diseases. The key driver of climate change is greenhouse gas emissions. Our health care system plays a large role, contributing close to 10% of our nation’s greenhouse gases. The US is also responsible for more than 25% of the world’s total health care emissions.
Within our health care system, pharmaceutica...
Source: Harvard Health Blog - April 22, 2021 Category: Consumer Health News Authors: Wynne Armand, MD Tags: Drugs and Supplements Environmental health Healthy Aging Source Type: blogs
